UnitedHealth Group Reports $113.2 Billion Revenue in Q3 2025, Net Earnings Decline 61%

UnitedHealth Group Inc. reported a consolidated revenue of $113.2 billion for the third quarter of 2025, marking a 12% increase from $100.8 billion in the same period last year. The growth was primarily driven by a 15% rise in premiums, which reached $89.0 billion, and a 7% increase in service revenues, totaling $9.8 billion. However, net earnings attributable to common shareholders fell to $2.3 billion, or $2.59 per diluted share, down 61% from $6.1 billion, or $6.51 per diluted share, in the prior year. The decline in profitability was attributed to elevated medical costs and the impact of the Change Healthcare cyberattack in 2024.

For the nine months ending September 30, 2025, total revenues increased to $334.4 billion, up from $299.5 billion in the same period of 2024. The company's operating costs also rose significantly, with medical costs increasing by 18% to $232.0 billion, reflecting higher care activity and costs associated with Medicare Advantage and Medicaid services. The medical care ratio (MCR) increased to 89.9% from 85.2%, indicating a higher proportion of medical costs relative to premium revenues.

Strategically, UnitedHealth Group completed several business combinations during the nine months, totaling $4.7 billion, which contributed to its growth. The company also reported an increase in customer counts, with UnitedHealthcare serving approximately 50.1 million individuals as of September 30, 2025, an increase of 795,000 from the previous year. Optum Health, a key segment of the company, served around 96 million people, although this was a decrease from 104 million in the prior year, reflecting challenges in the risk-based contract environment.

In terms of operational metrics, UnitedHealth Group's cash flows from operations for the nine months ended September 30, 2025, were $18.6 billion, down from $21.8 billion in the previous year. The company maintained a strong liquidity position, with cash and cash equivalents totaling $27.2 billion as of September 30, 2025. The company also increased its quarterly cash dividend to an annual rate of $8.84 per share, up from $8.40, reflecting its commitment to returning value to shareholders.

Looking ahead, UnitedHealth Group anticipates continued growth in the health care market, driven by demographic trends and advancements in medical technology. However, the company faces challenges related to rising medical costs, regulatory pressures, and competitive dynamics in the health insurance sector. The management remains focused on cost management and operational efficiencies to navigate these challenges while pursuing strategic growth opportunities.